Correction to: Loss of the BMP Antagonist, SMOC-1, Causes Ophthalmo-Acromelic (Waardenburg Anophthalmia) Syndrome in Humans and Mice (PLoS Genetics, (2011), 7, 7, (e1002114), 10.1371/journal.pgen.1002114);Loss of the BMP antagonist, SMOC-1, causes Ophthalmo-acromelic (Waardenburg anophthalmia) syndrome in humans and mice

PLoS Genetics

Volumn 7, Issue 7, 2011, Pages

  Rainger, Joe ^a   van Beusekom, Ellen ^b   Ramsay, Jacqueline K ^a   McKie, Lisa ^a   Al Gazali, Lihadh ^c   Pallotta, Rosanna ^d   Saponari, Anita ^d   Branney, Peter ^a   Fisher, Malcolm ^a   Morrison, Harris ^a   Bicknell, Louise ^a   Gautier, Philippe ^a   Perry, Paul ^a   Sokhi, Kishan ^a,e   Sexton, David ^a   Bardakjian, Tanya M ^f   Schneider, Adele S ^f   Elcioglu, Nursel ^g   Ozkinay, Ferda ^h   Koenig, Rainer ⁱ   Mégarbané, Andre ^j   Semerci, C Nur ^k   Khan, Ayesha ^l   Zafar, Saemah ^l   Hennekam, Raoul ^m   Sousa, Sérgio B ⁿ   Ramos, Lina ⁿ   Garavelli, Livia ^o   Furga, Andrea Superti ^p   Wischmeijer, Anita ^o   Jackson, Ian J ^a   Gillessen Kaesbach, Gabriele ^q   Brunner, Han G ^b   Wieczorek, Dagmar ^r   van Bokhoven, Hans ^b   FitzPatrick, David R ^a   more..

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^d UNIVERSITY OF CHIETI   (Italy)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f ALBERT EINSTEIN MEDICAL CENTER   (United States)

^g MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^h EGE UNIVERSITY   (Turkey)

ⁱ GOETHE UNIVERSITY   (Germany)

^j SAINT JOSEPH UNIVERSITY   (Lebanon)

^k PAMUKKALE UNIVERSITY   (Turkey)

^l AL SHIFA TRUST EYE HOSPITAL   (Pakistan)

^m UNIVERSITY OF AMSTERDAM   (Netherlands)

ⁿ CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^o S MARIA NUOVA HOSPITAL   (Italy)

^p UNIVERSITY OF LAUSANNE   (Switzerland)

^q UNIVERSITY OF LÜBECK   (Germany)

^r UNIVERSITY HOSPITAL ESSEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; DECAPENTAPLEGIC PROTEIN; MESSENGER RNA; BMP1 PROTEIN, HUMAN; BMP1 PROTEIN, MOUSE; OSTEONECTIN; PROCOLLAGEN C PROTEINASE; SMOC 1 PROTEIN, MOUSE; SMOC-1 PROTEIN, MOUSE; SMOC1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ANIMAL TISSUE; ARTICLE; CHILD; CLEFT PALATE; CLINICAL ARTICLE; COLOBOMA; DOWN REGULATION; DROSOPHILA; EMBRYO; FEMALE; FRAMESHIFT MUTATION; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE TARGETING; GENETIC LINKAGE; HINDLIMB; HOMOZYGOSITY; HUMAN; INFANT; LOSS OF FUNCTION MUTATION; MALE; MICROSATELLITE MARKER; MISSENSE MUTATION; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NONSENSE MUTATION; SCHOOL CHILD; SMOC1 GENE; WAARDENBURG SYNDROME; XENOPUS LAEVIS; ANIMAL; ANIMAL MODEL; ANOPHTHALMIA; C57BL MOUSE; DRUG ANTAGONISM; EYE; GENETICS; GROWTH, DEVELOPMENT AND AGING; LIMB; METABOLISM; MOUSE MUTANT; MUTATION; NUCLEOTIDE SEQUENCE; PEDIGREE; SYNDACTYLY;

ANIMALIA; MAMMALIA; MUS; XENOPUS LAEVIS;

ANIMALS; ANOPHTHALMOS; BONE MORPHOGENETIC PROTEIN 1; COLOBOMA; DNA MUTATIONAL ANALYSIS; EXTREMITIES; EYE; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; MUTATION; OSTEONECTIN; PEDIGREE; SYNDACTYLY; WAARDENBURG'S SYNDROME; XENOPUS LAEVIS;

EID: 79960938476     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1007866     Document Type: Erratum

References (62)

1. Morrison D, FitzPatrick D, Hanson I, Williamson K, van Heyningen V, et al. (2002) National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiology. J Med Genet 39: 16-22.
2. Fantes J, Ragge NK, Lynch SA, McGill NI, Collin JR, et al. (2003) Mutations in SOX2 cause anophthalmia. Nat Genet 33: 461-463.
3. Ragge NK, Lorenz B, Schneider A, Bushby K, de Sanctis L, et al. (2005) SOX2 anophthalmia syndrome. Am J Med Genet A 135: 1-7 discussion 8.
4. Williamson KA, Hever AM, Rainger J, Rogers RC, Magee A, et al. (2006) Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome. Hum Mol Genet 15: 1413-1422.
5. Ragge NK, Brown AG, Poloschek CM, Lorenz B, Henderson RA, et al. (2005) Heterozygous mutations of OTX2 cause severe ocular malformations. Am J Hum Genet 76: 1008-1022.
6. Henderson RH, Williamson KA, Kennedy JS, Webster AR, Holder GE, et al. (2009) A rare de novo nonsense mutation in OTX2 causes early onset retinal dystrophy and pituitary dysfunction. Mol Vis 15: 2442-2447.
7. Pasutto F, Sticht H, Hammersen G, Gillessen-Kaesbach G, Fitzpatrick DR, et al. (2007) Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am J Hum Genet 80: 550-560.
8. Bakrania P, Efthymiou M, Klein JC, Salt A, Bunyan DJ, et al. (2008) Mutations in BMP4 cause eye, brain, and digit developmental anomalies: overlap between the BMP4 and hedgehog signaling pathways. Am J Hum Genet 82: 304-319.
9. Waardenburg PJ, (1961) Autosomally-recessive anophthalmia with malformations of the hands and feet. In: P. J. Waardenburg AFaDK, editors. Vol I. Assen, The Netherlands: Royal Van Gorcum.
10. Abouzeid H, Boisset G, Favez T, Youssef M, Marzouk I, et al. (2011) Mutations in the SPARC-related modular calcium-binding protein 1 gene, SMOC1, cause waardenburg anophthalmia syndrome. Am J Hum Genet 88: 92-98.
11. LI AG, Sabarinathan DK A K, (1994) Microphthalmia and distal limb abnormalities in a child of consanguineous parents. Clin Dysmorphol 3: 258-262.
12. Caksen H, Odabas D, Oner AF, Abuhandan M, Calebi V, (2002) Ophthalmo-acromelic syndrome in a Turkish infant: case report. East Afr Med J 79: 339-340.
13. Cogulu O, Ozkinay F, Gunduz C, Sapmaz G, Ozkinay C, (2000) Waardenburg anophthalmia syndrome: report and review. Am J Med Genet 90: 173-174.
14. Galasso C, Bombardieri R, Cerminara C, Stranci G, Curatolo P, (2007) Anophthalmia-Waardenburg syndrome with expanding phenotype: does neural crest play a role? J Child Neurol 22: 1252-1255.
15. Gambhir PS, Gambhir SP, Bankar SM, (2010) Ophthalmoacromelic syndrome: two further cases expanding the phenotype. Clin Dysmorphol 19: 91-94.
16. Garavelli L, Pedori S, Dal Zotto R, Franchi F, Marinelli M, et al. (2006) Anophthalmos with limb anomalies (Waardenburg opththalmo-acromelic syndrome): report of a new Italian case with renal anomaly and review. Genet Couns 17: 449-455.
17. Hamanoue H, Megarbane A, Tohma T, Nishimura A, Mizuguchi T, et al. (2009) A locus for ophthalmo-acromelic syndrome mapped to 10p11.23. Am J Med Genet A 149A: 336-342.
18. Kara F, Yesildaglar N, Tuncer RA, Semerci N, Onat N, et al. (2002) A case report of prenatally diagnosed ophthalmo-acromelic syndrome type Waardenburg. Prenat Diagn 22: 395-397.
19. Khan A, Zafar SN, (2008) Pierre Robin sequence with unilateral anophthalmia and lower limb oligodactyly: an unusual presentation of ophthalmoacromelic syndrome? Clin Dysmorphol 17: 187-188.
20. Le Merrer M, Nessmann C, Briard ML, Maroteaux P, (1988) Ophthalmo-acromelic syndrome. Ann Genet 31: 226-229.
21. Megarbane A, Souraty N, Tamraz J, (1998) Ophthalmo-acromelic syndrome (Waardenburg) with split hand and polydactyly. Genet Couns 9: 195-199.
22. Pallotta R, Dallapiccola B, (1984) A syndrome with true anophthalmia, hand-foot defects and mental retardation. Ophthalmic Paediatr Genet 4: 19-23.
23. Quarrell OW, (1995) Ophthalmo acromelic syndrome. Clin Dysmorphol 4: 272-273.
24. Richieri-Costa A, Gollop TR, Otto PG, (1983) Brief clinical report: autosomal recessive anophthalmia with multiple congenital abnormalities-type Waardenburg. Am J Med Genet 14: 607-615.
25. Sayli BS, Akarsu AN, Altan S, (1995) Anophthalmos-syndactyly (Waardenburg) syndrome without oligodactyly of toes. Am J Med Genet 58: 18-20.
26. Suyugul Z, Seven M, Hacihanefioglu S, Kartal A, Suyugul N, et al. (1996) Anophthalmia-Waardenburg syndrome: a report of three cases. Am J Med Genet 62: 391-397.
27. Teiber ML, Garrido JA, Barreiro CZ, (2007) Ophthalmo-acromelic syndrome: report of a case with vertebral anomalies. Am J Med Genet A 143A: 2460-2462.
28. Tekin M, Tutar E, Arsan S, Atay G, Bodurtha J, (2000) Ophthalmo-acromelic syndrome: report and review. Am J Med Genet 90: 150-154.
29. Traboulsi EI, Nasr AM, Fahd SD, Jabbour NM, Der Kaloustian VM, (1984) Waardenburg's recessive anophthalmia syndrome. Ophthalmic Paediatr Genet 4: 13-18.
30. Hopkins DR, Keles S, Greenspan DS, (2007) The bone morphogenetic protein 1/Tolloid-like metalloproteinases. Matrix Biol 26: 508-523.
31. Sieber C, Kopf J, Hiepen C, Knaus P, (2009) Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev 20: 343-355.
32. Miyazono K, Kamiya Y, Morikawa M, (2010) Bone morphogenetic protein receptors and signal transduction. J Biochem 147: 35-51.
33. Hu MC, Wasserman D, Hartwig S, Rosenblum ND, (2004) p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1. J Biol Chem 279: 12051-12059.
34. De Robertis EM, (2006) Spemann's organizer and self-regulation in amphibian embryos. Nat Rev Mol Cell Biol 7: 296-302.
35. Wills A, Harland RM, Khokha MK, (2006) Twisted gastrulation is required for forebrain specification and cooperates with Chordin to inhibit BMP signaling during X. tropicalis gastrulation. Dev Biol 289: 166-178.
36. Ambrosio AL, Taelman VF, Lee HX, Metzinger CA, Coffinier C, et al. (2008) Crossveinless-2 Is a BMP feedback inhibitor that binds Chordin/BMP to regulate Xenopus embryonic patterning. Dev Cell 15: 248-260.
37. Dale L, Evans W, Goodman SA, (2002) Xolloid-related: a novel BMP1/Tolloid-related metalloprotease is expressed during early Xenopus development. Mech Dev 119: 177-190.
38. Yan X, Lin Z, Chen F, Zhao X, Chen H, et al. (2009) Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. J Biol Chem 284: 30097-30104.
39. Vannahme C, Smyth N, Miosge N, Gosling S, Frie C, et al. (2002) Characterization of SMOC-1, a novel modular calcium-binding protein in basement membranes. J Biol Chem 277: 37977-37986.
40. Vannahme C, Gosling S, Paulsson M, Maurer P, Hartmann U, (2003) Characterization of SMOC-2, a modular extracellular calcium-binding protein. Biochem J 373: 805-814.
41. Novinec M, Kordis D, Turk V, Lenarcic B, (2006) Diversity and evolution of the thyroglobulin type-1 domain superfamily. Mol Biol Evol 23: 744-755.
42. Thomas JT, Canelos P, Luyten FP, Moos MJ, (2009) Xenopus SMOC-1 Inhibits bone morphogenetic protein signaling downstream of receptor binding and is essential for postgastrulation development in Xenopus. J Biol Chem 284: 18994-19005.
43. Friedel RH, Seisenberger C, Kaloff C, Wurst W, (2007) EUCOMM-the European conditional mouse mutagenesis program. Brief Funct Genomic Proteomic 6: 180-185.
44. Hitzel C, Kanzler H, Konig A, Kummer MP, Brix K, et al. (2000) Thyroglobulin type-I-like domains in invariant chain fusion proteins mediate resistance to cathepsin L digestion. FEBS Lett 485: 67-70.
45. Pungercic G, Dolenc I, Dolinar M, Bevec T, Jenko S, et al. (2002) Individual recombinant thyroglobulin type-1 domains are substrates for lysosomal cysteine proteinases. Biol Chem 383: 1809-1812.
46. Lu J, Qian J, Keppler D, Cardoso WV, (2007) Cathespin H is an Fgf10 target involved in Bmp4 degradation during lung branching morphogenesis. J Biol Chem 282: 22176-22184.
47. Stopper GF, Wagner GP, (2007) Inhibition of Sonic hedgehog signaling leads to posterior digit loss in Ambystoma mexicanum: parallels to natural digit reduction in urodeles. Dev Dyn 236: 321-331.
48. Towers M, Mahood R, Yin Y, Tickle C, (2008) Integration of growth and specification in chick wing digit-patterning. Nature 452: 882-886.
49. Katagiri T, Boorla S, Frendo JL, Hogan BL, Karsenty G, (1998) Skeletal abnormalities in doubly heterozygous Bmp4 and Bmp7 mice. Dev Genet 22: 340-348.
50. Robert B, (2007) Bone morphogenetic protein signaling in limb outgrowth and patterning. Dev Growth Differ 49: 455-468.
51. Ashe HL, Briscoe J, (2006) The interpretation of morphogen gradients. Development 133: 385-394.
52. Schwank G, Basler K, (2010) Regulation of organ growth by morphogen gradients. Cold Spring Harb Perspect Biol 2: a001669.
53. Affolter M, Basler K, (2007) The Decapentaplegic morphogen gradient: from pattern formation to growth regulation. Nat Rev Genet 8: 663-674.
54. Vuilleumier R, Springhorn A, Patterson L, Koidl S, Hammerschmidt M, et al. (2010) Control of Dpp morphogen signalling by a secreted feedback regulator. Nat Cell Biol 12: 611-617.
55. Rogulja D, Irvine KD, (2005) Regulation of cell proliferation by a morphogen gradient. Cell 123: 449-461.
56. Maatouk DM, Choi KS, Bouldin CM, Harfe BD, (2009) In the limb AER Bmp2 and Bmp4 are required for dorsal-ventral patterning and interdigital cell death but not limb outgrowth. Dev Biol 327: 516-523.
57. Pajni-Underwood S, Wilson CP, Elder C, Mishina Y, Lewandoski M, (2007) BMP signals control limb bud interdigital programmed cell death by regulating FGF signaling. Development 134: 2359-2368.
58. Chang B, Smith RS, Peters M, Savinova OV, Hawes NL, et al. (2001) Haploinsufficient Bmp4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure. BMC Genet 2: 18.
59. Furuta Y, Hogan BL, (1998) BMP4 is essential for lens induction in the mouse embryo. Genes Dev 12: 3764-3775.
60. Suzuki S, Marazita ML, Cooper ME, Miwa N, Hing A, et al. (2009) Mutations in BMP4 are associated with subepithelial, microform, and overt cleft lip. Am J Hum Genet 84: 406-411.
61. Okada I, Hamanoue H, Terada K, Tohma T, Megarbane A, et al. (2011) SMOC1 is essential for ocular and limb development in humans and mice. Am J Hum Genet 88: 30-41.
62. Harewood L, Liu M, Keeling J, Howatson A, Whiteford M, et al. (2010) Bilateral renal agenesis/hypoplasia/dysplasia (BRAHD): postmortem analysis of 45 cases with breakpoint mapping of two de novo translocations. PLoS ONE 5: e12375 doi:10.1371/journal.pone.0012375.